Humoral and cellular immunity in convalescent and vaccinated COVID-19 people with multiple sclerosis: Effects of disease modifying therapies

OBJECTIVES: To determine anti-SARS-Cov2 antibodies and T-cell immunity in convalescent people with multiple sclerosis (pwMS) and/or pwMS vaccinated against Covid-19, depending on the disease modifying therapy, and in comparison to healthy controls (HC). METHODS: 75 participants were enrolled: Group...

Descripción completa

Detalles Bibliográficos
Autores principales: Habek, Mario, Željko, Cvetić, Savić Mlakar, Ana, Bendelja, Krešo, Rogić, Dunja, Adamec, Ivan, Barun, Barbara, Gabelić, Tereza, Krbot Skorić, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824161/
https://www.ncbi.nlm.nih.gov/pubmed/35158189
http://dx.doi.org/10.1016/j.msard.2022.103682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824161/
https://www.ncbi.nlm.nih.gov/pubmed/35158189
http://dx.doi.org/10.1016/j.msard.2022.103682

Ejemplares similares